Immune suppression for childhood acquired aplastic anemia and myelodysplastic syndrome: where next?
about
Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in ChildhoodIndications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Induction of short-term remission with single agent eltrombopag in refractory nucleophosmin-1-mutated acute myeloid leukemia.Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.
P2860
Immune suppression for childhood acquired aplastic anemia and myelodysplastic syndrome: where next?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Immune suppression for childho ...... splastic syndrome: where next?
@en
Immune suppression for childho ...... splastic syndrome: where next?
@nl
type
label
Immune suppression for childho ...... splastic syndrome: where next?
@en
Immune suppression for childho ...... splastic syndrome: where next?
@nl
prefLabel
Immune suppression for childho ...... splastic syndrome: where next?
@en
Immune suppression for childho ...... splastic syndrome: where next?
@nl
P2093
P2860
P1433
P1476
Immune suppression for childho ...... splastic syndrome: where next?
@en
P2093
Carlo Dufour
Judith Marsh
Sujith Samarasinghe
P2860
P304
P356
10.3324/HAEMATOL.2014.105569
P577
2014-04-01T00:00:00Z